menu search

TBRIF / Therma Bright to invest up to US$2.5M in developer of a groundbreaking ischemic stroke treatment

Therma Bright to invest up to US$2.5M in developer of a groundbreaking ischemic stroke treatment
Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) said it has signed a share purchase agreement to buy up to a 25% stake in Inretio Ltd, an Israel-based company developing a medical device to treat ischemic stroke. Under the terms of the deal, Therma Bright has the right to invest US$2 million in cash and $500,000 in stock, paid upon certain milestone achievements through May 31, 2024. Read More
Posted: Jan 19 2023, 09:11
Author Name: Proactive Investors
Views: 101841

TBRIF News  

Therma Bright appoints Eric Myung as new CEO

By Proactive Investors
October 2, 2023

Therma Bright appoints Eric Myung as new CEO

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) told investors that Eric Myung has assumed the role of the company's new chief financial officer (CFO) with more_horizontal

Therma Bright says permanent insurance codes for Venowave expected over coming weeks

By Proactive Investors
August 4, 2023

Therma Bright says permanent insurance codes for Venowave expected over coming weeks

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) said that in the coming weeks, it expects a final decision on permanent codes from the Centers for Medicare more_horizontal

Therma Bright in talks with US Health and Human Services over permanent medical device codes

By Proactive Investors
June 30, 2023

Therma Bright in talks with US Health and Human Services over permanent medical device codes

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) said it has been engaged in discussions with the US Department of Health and Human Services (DHHS) over the more_horizontal

Therma Bright seeking commercialization opportunities for its AI-driven Digital Cough Technology

By Proactive Investors
June 22, 2023

Therma Bright seeking commercialization opportunities for its AI-driven Digital Cough Technology

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF). announced that it has begun investigating opportunities to commercialize and monetize its artificial intel more_horizontal

Therma Bright hails successful Good Laboratory Practice study for breakthrough PREVA mechanical thrombectomy device

By Proactive Investors
June 8, 2023

Therma Bright hails successful Good Laboratory Practice study for breakthrough PREVA mechanical thrombectomy device

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) along with its partner Inretio Inc has highlighted the successful completion of a Good Laboratory Practice more_horizontal

Therma Bright expands Venowave's US distribution to boost sales using Medicaid and Medicare reimbursement codes

By Proactive Investors
May 25, 2023

Therma Bright expands Venowave's US distribution to boost sales using Medicaid and Medicare reimbursement codes

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) announced that it is working with its US distributor network on expanding sales of Venowave under the nine t more_horizontal

Therma Bright kicks off data collection with AI App at tuberculosis clinics in Pakistan

By Proactive Investors
May 10, 2023

Therma Bright kicks off data collection with AI App at tuberculosis clinics in Pakistan

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) announced that it has established collaborations with several tuberculosis (TB) medical care facilities to i more_horizontal

Therma Bright secures US Medicare and Medicaid reimbursement for its Venowave devices

By Proactive Investors
April 14, 2023

Therma Bright secures US Medicare and Medicaid reimbursement for its Venowave devices

Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) said it has successfully secured US Medicare and Medicaid reimbursement through various payers, with the rei more_horizontal


Search within

Pages Search Results: